Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | NGLFINE NGL Fine-Chem Limited Pharma · Small | ARVEE Arvee Laboratories (India) Limited Pharma · Small | LASA Lasa Supergenerics Limited Pharma · Small | INFINIUM Infinium Pharmachem Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 35 | 21 | 5 | 49 |
| Verdict | WATCHLIST | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | WATCHLIST | OVERVALUED | Distress Watch | Financial Turnaround |
| Piotroski | 8/9 | 5/9 | 2/9 | 8/9 |
| Valuation | 0/30 | 0/30 | 5/30 | 10/30 |
| Growth | 6/25 | 11/25 | 0/25 | 16/25 |
| Quality | 11/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 11/15 | 5/15 | 12/15 |
| Cash Flow | 3/10 | 3/10 | 3/10 | 8/10 |
| Price | ₹2,820.7 | ₹163.57 | ₹7.61 | ₹206.75 |
| P/E | 34.10 | 69.60 | — | 26.20 |
| P/B | 4.98 | 5.21 | 0.78 | 2.63 |
| ROE | 15.70% | 7.78% | -19.60% | 10.50% |
| ROCE | 17.00% | 7.92% | -18.20% | 13.10% |
| Debt / Equity | 0.33 | 0.03 | 0.20 | 0.00 |
| FCF Yield | — | 0.22% | — | 8.49% |
| Dividend Y | 0.07% | — | — | — |
| Altman Z | 6.95 | 7.99 | 1.73 | 6.12 |
| Promoter % | 72.73% | 73.50% | 53.65% | 64.91% |
| Mkt Cap (₹Cr) | 1640.00 | 176.00 | 38.20 | 318.00 |
| Graham # | ₹966.61 | ₹39.86 | — | ₹116.77 |
| Fair PE | 6.2 | 42.0 | 1.3 | 42.0 |
| MoS % | -482.0% | -69.3% | — | +36.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startNGLFINE138
ARVEE96
LASA27
INFINIUM83